About KRS Pharmaceuticals
KRS Pharmaceuticals is a company based in Hyderabad (India) by Narendra Balusu and Lakshmana Swamy Balusu. It operates as a B2B. The company has 55 employees as of March 31, 2023. KRS Pharmaceuticals operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
- Headquarter Hyderabad, India
- Employees 55 as on 31 Mar, 2023
- Founders Narendra Balusu, Lakshmana Swamy Balusu
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Krs Pharmaceuticals Private Limited
- Date of Incorporation 12 Sep, 2000
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$5.84 M (USD)-11.02as on Mar 31, 2023
-
Net Profit
$71.72 K (USD)-76.86as on Mar 31, 2023
-
EBITDA
$429.84 K (USD)-41.29as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
55
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of KRS Pharmaceuticals
Detailed funding history for KRS Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by KRS Pharmaceuticals
Investment portfolio details for KRS Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - KRS Pharmaceuticals
Detailed financials for KRS Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Krs Pharmaceuticals Comparisons
Peer comparison for KRS Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of KRS Pharmaceuticals
KRS Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services for small molecules are provided.
|
|
| Locked | Locked | Locked |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| Locked | Locked | Locked |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| Locked | Locked | Locked |
Generic drugs and clinical research services are provided globally.
|
|
| Locked | Locked | Locked |
Laboratory testing, clinical trial research, and biopharma services are provided.
|
|
| Locked | Locked | Locked |
AI powered scientific data management and workflow automation solutions
|
Detailed competitors of KRS Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Krs Pharmaceuticals
Complete news archive for KRS Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KRS Pharmaceuticals
KRS Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2023, the latest employee count at KRS Pharmaceuticals is 55.
Annual revenue of KRS Pharmaceuticals is $5.84M as on Mar 31, 2023.
KRS Pharmaceuticals operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and chemical intermediates. Manufactures chemicals and intermediates while providing contract research services for the pharmaceutical industry. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.